ClinicalTrials.Veeva

Menu

Evaluation of PCLs Using Three EUS-FNA Needles

Boston Scientific logo

Boston Scientific

Status

Completed

Conditions

Pancreatic Cystic Lesions

Treatments

Device: 22 G Needle
Device: 19 G Needle
Device: 19 G Flex Needle

Study type

Interventional

Funder types

Industry

Identifiers

NCT01711294
E7084 (Other Identifier)
90869947

Details and patient eligibility

About

To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to obtain sufficient material for standard diagnostic testing, and on diagnostic accuracy of EUS-FNA aspirate for differentiation of mucinous (pre-malignant) and non-mucinous cysts.

Enrollment

250 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pancreatic cystic lesion measuring 13mm or greater in largest diameter.
  • Indicated for EUS evaluation of the PCL including EUS-FNA.
  • Age 18 years of age or older.
  • Willing and able to comply with the study procedures and provide written informed consent form to participate in the study.

Exclusion criteria

  • Cysts in which FNA is not indicated based on review by the clinician, including potential concern of blood vessel location relative to the cyst.
  • Requirement for anticoagulation using clopidogril, warfarin, or other long acting antiplatelet agents (with the exception of aspirin) that cannot be safely stopped according to institutional guidelines.
  • Standard contraindications for EUS.
  • Known pancreatic pseudocyst.
  • Pregnancy.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 3 patient groups

19 G Flex Needle
Active Comparator group
Description:
Device: Expect™ Endoscopic Ultrasound Aspiration Needle (19 G Flex)
Treatment:
Device: 19 G Flex Needle
22 G Needle
Active Comparator group
Description:
Device: Expect™ Endoscopic Ultrasound Aspiration Needle (22 G)
Treatment:
Device: 22 G Needle
19 G Needle
Active Comparator group
Description:
Device: Expect™ Endoscopic Ultrasound Aspiration Needle (19 G)
Treatment:
Device: 19 G Needle

Trial documents
2

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems